PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial: Rationale and design

Margaret May Redfield, Barry A Borlaug, Greg D. Lewis, Selma F. Mohammed, Marc J. Semigran, Martin M. Lewinter, Anita Deswal, Adrian F. Hernandez, Kerry L. Lee, Eugene Braunwald

Research output: Contribution to journalArticle

82 Citations (Scopus)
Original languageEnglish (US)
Pages (from-to)653-659
Number of pages7
JournalCirculation: Heart Failure
Volume5
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Piperazines
Diastolic Heart Failure
Phosphodiesterase 5 Inhibitors
Cardiovascular Agents
Purines
Sulfones
Exercise Tolerance
Phosphodiesterase Inhibitors
Doppler Echocardiography
Recovery of Function
Exercise Test
Left Ventricular Function
Double-Blind Method
Oxygen Consumption
Research Design
Heart Failure
Magnetic Resonance Imaging
Surveys and Questionnaires

Keywords

  • Diastolic heart failure
  • Heart failure
  • Phosphodiesterase inhibitor

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial : Rationale and design. / Redfield, Margaret May; Borlaug, Barry A; Lewis, Greg D.; Mohammed, Selma F.; Semigran, Marc J.; Lewinter, Martin M.; Deswal, Anita; Hernandez, Adrian F.; Lee, Kerry L.; Braunwald, Eugene.

In: Circulation: Heart Failure, Vol. 5, No. 5, 09.2012, p. 653-659.

Research output: Contribution to journalArticle

Redfield, Margaret May ; Borlaug, Barry A ; Lewis, Greg D. ; Mohammed, Selma F. ; Semigran, Marc J. ; Lewinter, Martin M. ; Deswal, Anita ; Hernandez, Adrian F. ; Lee, Kerry L. ; Braunwald, Eugene. / PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial : Rationale and design. In: Circulation: Heart Failure. 2012 ; Vol. 5, No. 5. pp. 653-659.
@article{27fd859979464e7f842b73eacc0480ce,
title = "PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial: Rationale and design",
keywords = "Diastolic heart failure, Heart failure, Phosphodiesterase inhibitor",
author = "Redfield, {Margaret May} and Borlaug, {Barry A} and Lewis, {Greg D.} and Mohammed, {Selma F.} and Semigran, {Marc J.} and Lewinter, {Martin M.} and Anita Deswal and Hernandez, {Adrian F.} and Lee, {Kerry L.} and Eugene Braunwald",
year = "2012",
month = "9",
doi = "10.1161/CIRCHEARTFAILURE.112.969071",
language = "English (US)",
volume = "5",
pages = "653--659",
journal = "Circulation: Heart Failure",
issn = "1941-3297",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - PhosphdiesteRasE-5 inhibition to improve CLinical status and EXercise capacity in diastolic heart failure (RELAX) trial

T2 - Rationale and design

AU - Redfield, Margaret May

AU - Borlaug, Barry A

AU - Lewis, Greg D.

AU - Mohammed, Selma F.

AU - Semigran, Marc J.

AU - Lewinter, Martin M.

AU - Deswal, Anita

AU - Hernandez, Adrian F.

AU - Lee, Kerry L.

AU - Braunwald, Eugene

PY - 2012/9

Y1 - 2012/9

KW - Diastolic heart failure

KW - Heart failure

KW - Phosphodiesterase inhibitor

UR - http://www.scopus.com/inward/record.url?scp=84868651278&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84868651278&partnerID=8YFLogxK

U2 - 10.1161/CIRCHEARTFAILURE.112.969071

DO - 10.1161/CIRCHEARTFAILURE.112.969071

M3 - Article

C2 - 22991405

AN - SCOPUS:84868651278

VL - 5

SP - 653

EP - 659

JO - Circulation: Heart Failure

JF - Circulation: Heart Failure

SN - 1941-3297

IS - 5

ER -